Nomura Holdings Inc. Takes $1.05 Million Position in Chemed Co. (NYSE:CHE)

Nomura Holdings Inc. acquired a new position in shares of Chemed Co. (NYSE:CHE - Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm acquired 1,988 shares of the company's stock, valued at approximately $1,053,000.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the business. CIBC Asset Management Inc lifted its stake in Chemed by 5.1% during the fourth quarter. CIBC Asset Management Inc now owns 457 shares of the company's stock worth $242,000 after purchasing an additional 22 shares during the period. CBIZ Investment Advisory Services LLC lifted its position in shares of Chemed by 64.7% during the 4th quarter. CBIZ Investment Advisory Services LLC now owns 56 shares of the company's stock worth $30,000 after buying an additional 22 shares during the period. CIBC Private Wealth Group LLC boosted its stake in Chemed by 13.5% in the 4th quarter. CIBC Private Wealth Group LLC now owns 185 shares of the company's stock valued at $98,000 after buying an additional 22 shares in the last quarter. Independent Advisor Alliance boosted its stake in Chemed by 1.1% in the 4th quarter. Independent Advisor Alliance now owns 2,279 shares of the company's stock valued at $1,207,000 after buying an additional 25 shares in the last quarter. Finally, EverSource Wealth Advisors LLC grew its position in Chemed by 7.1% in the fourth quarter. EverSource Wealth Advisors LLC now owns 498 shares of the company's stock valued at $264,000 after acquiring an additional 33 shares during the period. 95.85% of the stock is owned by institutional investors.

Analyst Ratings Changes

A number of equities research analysts recently issued reports on CHE shares. Wall Street Zen upgraded shares of Chemed from a "hold" rating to a "buy" rating in a research report on Friday, March 7th. Royal Bank of Canada lifted their target price on shares of Chemed from $667.00 to $674.00 and gave the company an "outperform" rating in a research note on Monday, April 28th.

Chemed Trading Down 1.7%

Shares of Chemed stock traded down $9.75 during midday trading on Thursday, reaching $561.47. The company had a trading volume of 175,244 shares, compared to its average volume of 102,455. The stock has a fifty day simple moving average of $585.27 and a 200 day simple moving average of $564.84. Chemed Co. has a 1-year low of $512.12 and a 1-year high of $623.61. The company has a market capitalization of $8.21 billion, a price-to-earnings ratio of 28.37, a price-to-earnings-growth ratio of 2.15 and a beta of 0.59.

Chemed (NYSE:CHE - Get Free Report) last released its earnings results on Wednesday, April 23rd. The company reported $5.63 earnings per share for the quarter, topping analysts' consensus estimates of $5.59 by $0.04. The company had revenue of $646.94 million during the quarter, compared to the consensus estimate of $641.78 million. Chemed had a return on equity of 27.86% and a net margin of 12.69%. The firm's quarterly revenue was up 9.8% on a year-over-year basis. During the same quarter in the previous year, the company posted $5.20 earnings per share. Sell-side analysts expect that Chemed Co. will post 21.43 earnings per share for the current year.

Chemed Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 17th. Stockholders of record on Thursday, May 29th will be issued a $0.50 dividend. The ex-dividend date of this dividend is Thursday, May 29th. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.36%. Chemed's dividend payout ratio (DPR) is presently 9.74%.

Insider Activity

In related news, EVP Spencer S. Lee sold 1,500 shares of the company's stock in a transaction dated Friday, May 16th. The shares were sold at an average price of $577.99, for a total value of $866,985.00. Following the transaction, the executive vice president now owns 14,627 shares in the company, valued at approximately $8,454,259.73. This represents a 9.30% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Kevin J. Mcnamara sold 2,000 shares of the company's stock in a transaction that occurred on Thursday, March 6th. The shares were sold at an average price of $593.67, for a total value of $1,187,340.00. Following the completion of the transaction, the chief executive officer now directly owns 102,679 shares in the company, valued at $60,957,441.93. The trade was a 1.91% decrease in their position. The disclosure for this sale can be found here. Insiders have sold 7,500 shares of company stock worth $4,401,120 over the last ninety days. Insiders own 3.29% of the company's stock.

Chemed Company Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.